Neoplasm
Not recruitingStudy of Olaparib for Patients with Advanced Cancer Having HRRm or HRD Mutations
Ireland- Participants:18–64 years · 65+ years
- Substances:Olaparib
- Sponsor:Merck Sharp & Dohme LLC
Rare diseases
Investigational molecules
Locations
Back to Ireland157 clinical trials in Cork, Ireland across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Ireland
Ireland
Ireland
Ireland
Ireland
Ireland
Ireland
Ireland
Ireland
Ireland
Ireland
IrelandThe busiest research cities in the country
What the registry says about research in the country
Extensive clinical trials focusing on lung cancer treatments, including innovative therapies for non-small cell lung cancer and testing new drug combinations. Studies evaluating treatments for breast cancer, particularly in hormone receptor-positive and HER2-negative variants.
Multiple trials exploring combination therapies and novel treatment approaches for various cancer types.
Research initiatives examining treatments for chronic lymphocytic leukemia and lymphomas. Studies evaluating new therapeutic approaches for myelodysplastic syndromes, focusing on reducing transfusion dependency.
Innovative approaches combining multiple therapeutic agents to improve patient outcomes.
Clinical studies investigating treatments for Primary Sjögren's Disease and atopic dermatitis. Research on novel therapeutic approaches for inflammatory conditions and immune system disorders.
Focus on developing targeted therapies to improve patient quality of life.
Tell us about your condition – we search every trial in Europe and connect you with the right site.